Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Takeda, a Japanese pharmaceutical company, operates in Orth an der Donau, Lower Austria, with a focus on gene therapy products.The company has decided to sell most of this facility, impacting 190 of 330 employees.
This change stems from Takeda's global decision to discontinue research and preclinical activities in gene therapy using adeno-associated viruses (AAV), which was a key capability of the Orth site.
Takeda has pledged support for affected staff, offering counselling and job placement assistance.This decision, communicated internally in April 2023, did not affect Takeda's other Austrian sites in Vienna and Linz, where it employs over 4,500 staff.
Eurofound (2024), Takeda, Internal restructuring in Austria, factsheet number 202211, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/202211.